## Abstract ## Background Donepezil is a drug used for treatment in patients with Alzheimer's disease (AD). Information regarding the costβeffectiveness of this medication was previously rare in Asia. We used techniques of decision analysis and economic evaluation in conjunction with available loc
Modeling the Cost-Effectiveness of Galantamine for Mild to Moderately Severe Alzheimer's Disease in Korea
β Scribed by Guk-Hee Suh
- Book ID
- 109079079
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 174 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati
To determine whether donepezil treatment (10 mg/day over 24 weeks) is associated with delayed emergence of apathy in patients with mild to moderate Alzheimer's disease (AD) and to explore relationships between donepezil's effects on apathy and other Neuropsychiatric Inventory (NPI)measured behaviour
## Objective: To examine the reliability and the validity of the korean version of the sib (sib-k); and to determine its usefulness in patients with severe dementia. ## Methods: Sixty-five patients (56 women, nine men) who lived in a nursing home and met the criteria of the diagnostic and statist